Key facts
- ZiO Health’s last known valuation is $17.2M (Mar 2022).
- It has raised $2.8M; the latest was Bankruptcy: Liquidation in Jan 2026.
- Status: Out of Business.
- ·Watchlist + deal alerts for ZiO Health
- ·The full record, as it builds
Funding rounds
No funding rounds for ZiO Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZiO Health
Developer of multi-functional electronic devices designed to optimize health with molecular testing to improve patient outcomes. The company's devices are used for measuring, testing, and detecting the molecular composition of chemical and biological substances, for the presence, absence, or quantity of target molecules, enabling users to optimize their health and prevent sickness by getting home diagnostics and personalized testing.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 11
- Website
- zio-health.com/
- Ownership
- Out of Business
ZiO Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZiO Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZiO Health in its N-PORT filings yet. We sweep new filings monthly.